BlackRock Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $1.13M | Buy |
8,296
+33
| +0.4% | +$4.5K | ﹤0.01% | 2615 |
|
2016
Q3 | $1.64M | Sell |
8,263
-14
| -0.2% | -$2.79K | ﹤0.01% | 2308 |
|
2016
Q2 | $1.07M | Buy |
8,277
+5,296
| +178% | +$687K | ﹤0.01% | 2564 |
|
2016
Q1 | $279K | Buy |
2,981
+52
| +2% | +$4.87K | ﹤0.01% | 3079 |
|
2015
Q4 | $594K | Buy |
2,929
+56
| +2% | +$11.4K | ﹤0.01% | 2925 |
|
2015
Q3 | $417K | Sell |
2,873
-142
| -5% | -$20.6K | ﹤0.01% | 3083 |
|
2015
Q2 | $641K | Buy |
3,015
+526
| +21% | +$112K | ﹤0.01% | 3033 |
|
2015
Q1 | $577K | Buy |
+2,489
| New | +$577K | ﹤0.01% | 2875 |
|